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Abstract
Objective: Dental caries remains the most common disease worldwide and the use of fluoride
toothpaste is a most effective preventive public health measure to prevent it. Changes in diets
following globalization contribute to the development of dental caries in emerging economies. The
aim of this paper is to compare the cost and relative affordability of fluoride toothpaste in high-,
middle- and low-income countries. The hypothesis is that fluoride toothpaste is not equally
affordable in high-, middle- and low-income countries.
Methods: Data on consumer prices of fluoride toothpastes were obtained from a self-completion
questionnaire from 48 countries. The cost of fluoride toothpaste in high-, middle- and low-income
countries was compared and related to annual household expenditure as well as to days of work
needed to purchase the average annual usage of toothpaste per head.
Results: The general trend seems to be that the proportion of household expenditure required
to purchase the annual dosage of toothpaste increases as the country's per capita household
expenditure decreases. While in the UK for the poorest 30% of the population only 0.037 days of
household expenditure is needed to purchase the annual average dosage (182.5 g) of the lowest
cost toothpaste, 10.75 days are needed in Kenya. The proportion of annual household expenditure
ranged from 0.02% in the UK to 4% in Zambia to buy the annual average amount of lowest cost
toothpaste per head.
Conclusion: Significant inequalities in the affordability of this essential preventive care product
indicate the necessity for action to make it more affordable. Various measures to improve
affordability based on experiences from essential pharmaceuticals are proposed.
Introduction
Globalization has provoked changes in many facets of
human life, particularly in diet. Trends in the develop-
ment of dental caries in population have traditionally fol-
lowed developmental patterns where, as economies grow
and populations have access to a wider variety of food
products as a result of more income and trade, the rate of
tooth decay begins to increase. As countries become
wealthier, there is a trend to greater preference for a more
"western" diet, high in carbohydrates and refined sugars.
Rapid globalization of many economies has accelerated
this process [1]. These dietary changes have a substantial
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impact on diseases such as diabetes and dental caries
[2,3]. The cariogenic potential of diet emerges in areas
where fluoride supplementation is inadequate [4]. Dental
caries is a global health problem [5] and has a significant
negative impact on quality of life, economic productivity,
adult and children's general health and development.
Untreated dental caries in pre-school children is associ-
ated with poorer quality of life, discomfort, and difficul-
ties in ingesting food that can result in failure to gain
weight and impaired cognitive development [6]. Since
low-income countries cannot afford dental restorative
treatment [7] and in general the poor are most vulnerable
to the impacts of illness, they should be afforded a greater
degree of protection.
By WHO estimates one third of the world's population
have inadequate access to needed medicines primarily
because they cannot afford them [8]. Despite the inclu-
sion of sodium fluoride in the World Health Organiza-
tion's Essential Medicines Model List [9], the global
availability and accessibility of fluoride for the prevention
of dental caries remains a global problem. The optimal
use of fluoride is an essential and basic public health strat-
egy in the prevention and control of dental caries, the
most common non-communicable disease on the planet.
Although a whole range of fluoride vehicles are available
for fluoride use (drinking water, salt, milk, varnish, etc.),
the most widely used method for maintaining a constant
low level of fluoride in the oral environment is fluoride
toothpaste. As one of the key components of the WHO
endorsed Basic Package of Oral Care [10], the promotion of
affordable and effective fluoride toothpaste is important
for improving equity in oral health.
The promotion of brushing twice a day with fluoride
toothpaste is based on strong scientific evidence [11,12].
The widespread use of fluoride toothpaste has been recog-
nised as the single most important reason for the decline
of dental caries in developed countries during the 1970s
and 1980s [13]. An example is the United Kingdom where
the only organized preventive program has been that of
water fluoridation but that only about 9% of the UK pop-
ulation benefit from optimally fluoridated water [14]. The
introduction of fluoride toothpaste is the major most
likely contributing factor to the decline in caries witnessed
in the United Kingdom although other confounding fac-
tors inevitably play a role. More recently, the decline in
dental caries amongst school children in Nepal, a low-
income country, has been attributed to improved access to
affordable fluoride toothpaste in Nepal [15]. For many
low-income nations, fluoride toothpaste is probably the
only realistic population strategy for the control and pre-
vention of dental caries since cheaper alternatives such as
water or salt fluoridation are not feasible due to poor
infrastructure and limited financial and technological
resources. The use of topical fluoride e.g. in the form of
varnish or gels for dental caries prevention is similarly
impractical since it relies on repeated applications of flu-
oride by trained personnel on an individual basis and
therefore in terms of cost cannot be considered as part of
a population based preventive strategy.
Based on global estimates, about 500 million people uti-
lize fluoride toothpaste, 210 million have access to fluor-
idated water, 40 million have access to fluoridated salt,
and 60 million benefit from fluoride mouth rinses, tablets
and clinically applied fluoride [5]. Taking into account
the global population for 2007 is estimated to be 6.6 bil-
lion it can be assumed that only about 12.5% of the
world's population benefit from the caries preventive pos-
sibilities of fluoride toothpaste.
The use of an efficacious fluoride toothpaste is largely
dependent upon its socio-cultural integration in personal
oral hygiene habits, availability and the ability of individ-
uals to purchase and use it on a regular basis. The price of
fluoride toothpaste is believed to be too high in some
developing countries [16] and this might impede equita-
ble access. In a survey conducted at a hospital dental clinic
in Lagos, Nigeria 32.5% of the respondents reported that
the cost of toothpaste influenced their choice of brands
and 54% also reported that the availability of dentifrices
influenced their choice [17]. WHO endorses the develop-
ment and use of affordable fluoride toothpaste and
defines affordable toothpaste as "one that is available at a
price that allows people on low income to purchase it
[18]." To date there have not been any attempts to quan-
tify affordability or to suggest a reasonable retail price
which consumers might pay for fluoride toothpaste; nor
has there been any research to evaluate the effects of
affordability, purchasing, and utilisation. The aim of this
paper is to compare the cost and relative affordability of
fluoride toothpaste in high-, middle- and low-income
countries. The hypothesis is that fluoride toothpaste is not
equally affordable in high-, middle- and low-income
countries.
Methods
Study design
A cross-sectional survey of fluoride toothpaste brands and
the retail cost was conducted between December 2005
and March 2006. Data was collected on a self-completion
questionnaire that was distributed to dental associations,
non-governmental oral health organisations and individ-
uals around the world in 136 countries. They were asked
to provide in a tabulated format the brand name, the retail
price and the quantity/package size for as many brands
that could be identified on the local retail market. Several
international brands were specified to facilitate compari-
son. Since the price of toothpaste often differs accordingGlobalization and Health 2008, 4:7 http://www.globalizationandhealth.com/content/4/1/7
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to size sold, the price for a packaging size closest to 100 g/
100 ml was asked. In addition, information was sought
on the cheapest available fluoride toothpaste.
Data entry and statistical analysis
The study assumed the therapeutic dose of fluoride tooth-
paste to be a pea-sized amount (0.25 g). The annual cost
of fluoride toothpaste in US dollars per person was based
on the therapeutic dose used twice daily for a year, which
amounts to 182.5 g of toothpaste [19].
Toothpaste prices were obtained in national currency
units. The data for all brands reported were entered into
Microsoft Excel and converted to the annual cost
expressed in US dollars using international exchange rate
data (xe.com). In order to examine affordability, the
prices were first adjusted to the year 2003 because the eco-
nomic indicators used for comparisons were available
most completely for that year. The 2006 to 2003 price
adjustment was done using the inflation, GDP deflators
for the years 2003, and 2004, obtained from the World
Bank World Development Indicators 2006 [20]. For 2005,
the 2004 GDP deflator was used because the 2005 defla-
tor was not yet available.
The adjusted 2003 price and economic indicator data
were converted to a SAS dataset for calculation of the
median price for each country as well as other statistics
using PROC MEANS and PROC UNIVARIATE. Two sets of
comparisons were made, one using all products for which
prices were collected, the second using the four selected
international (or multinational brands) and the brand
available at the cheapest price only. The ratios were calcu-
lated to facilitate the analysis of affordability within coun-
tries and in order to make cross-country comparisons.
Household final consumption expenditures is the indica-
tor used to evaluate affordability within the countries
[20]. The per capita 2003 household final consumption
expenditures were calculated for the total population and
by income group, to allow for evaluation of the results by
population segments, e.g. the poorest 30%, 50%, and
70% of the population. The analysis of affordability
expressed the cost of the annually recommended dose of
fluoride toothpaste as a proportion of the available house-
hold expenditures required to purchase enough tooth-
paste for one person for one year at the lowest available
price. Affordability was also evaluated by estimating the
number of days of work required to buy the recom-
mended dose for one person for one year using the coun-
try's per capita annual income (basis 250 working days).
The measure chosen for affordability was a ratio of the
number of days needed to pay for one annual therapeutic
dosage of toothpaste at the lowest price for the poorest
30% of the population. According to Health Action Inter-
national (HAI) a medication costing more than the equiv-
alent of one day's wages is considered unaffordable [21].
The data from this affordability comparison was ranked
into high and low prices using the median number of days
of household final consumption income needed to pay
for one dosage of toothpaste using one day as the cut-off
point.
Results
A total of 136 countries were contacted and 45 countries
responded. Prices were obtained for 360 toothpaste prod-
ucts priced in 45 countries: 15 low-income, 17 middle-
income, and 13 high-income countries. Economic data
were available for 40 countries only, eliminating 3 low-
income and 2 middle-income countries from the analysis
(317 products). Where only the chosen international
brands and the most inexpensive toothpastes available
were analysed, data from 39 countries were used for a
total of 137 products.
Comparison of the ratio of the lowest and median tooth-
paste prices to household final consumption expendi-
tures, by country, showed that as the per capita income
decreases the proportion of annual per capita income
required for the annual therapeutic dose of toothpaste
increases (Figure 1). For the poorest 30% of the popula-
tion, the ratio for all toothpaste products surveyed ranges
from 0.015% (U.K) to 4.3% (Zambia) (median = 0.29; SD
= 0.8, whereas the median for the total population is
0.07% (range 0.004%–0.8%; SD = 0.18%). A similar
range and standard deviation were observed for prices for
the selected international and the cheapest available
brands only as proportion of annual household final con-
sumption expenditures per capita for the poorest 30% of
the population.
Affordability is illustrated in Figure 2 with ratios of the
lowest price of toothpaste as a proportion of one workday
of per capita income for all brands for the four income dis-
tribution levels. Countries are ranked by household final
consumption expenditures from highest on the left to
lowest on the right. The resulting estimates for the
number of workdays needed to pay for one annual dose
of toothpaste per person at the lowest price for the poorest
30% of the population, range from 0.03 days in the
United Kingdom to 9.34 days in Kenya (SD = 1.88), while
for the same countries over the total population the range
was 0.01–2. The range and standard deviation for the
poorest 30% of the population is comparable for both the
selected international brands and the lowest price brands.
When viewed by country category for all product brands
surveyed in 40 countries, the prices for the poorest 30% of
the population in each of 9 of the 12 (75%) of the lowestGlobalization and Health 2008, 4:7 http://www.globalizationandhealth.com/content/4/1/7
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income countries were categorized as high, while prices in
6 of 15 (40%) of the middle-income countries were high.
None of the high-income countries fell into the high cat-
egory. As wealthier income groups were aggregated into
the ratio the price category changed to the point where, for
the total population toothpaste seemed expensive in only
4 (33%) of the low income countries and none of the
middle income countries. Nonetheless for the lowest
income countries the price remained in the high category
in 7 of 12 countries for 70% of the population. In general,
global brands seem to be more expensive than the generic
brands.
Limitations of the study
This investigation is not a comprehensive study on fluo-
ride toothpaste affordability as only 24% of all World
Bank member countries (184) participated in the survey.
In addition, the data were predominantly collected from
urban retail shops, chosen by convenience. Variations in
retail cost of toothpaste and even of the same brands may
occur within countries, between urban and rural markets
and between countries due to natural factors (e.g. size of
packaging, transportation costs) structural factors (e.g.
local taxation and business regulations) and market con-
ditions [22]. Larger retailers or wholesalers can charge
lower prices, than small shops; whereas bargaining in
street markets may result in lower prices.
The World Health Organization (WHO) and Health
Action International (HAI) are field-testing a methodol-
ogy for detailed country studies of affordability and costs
of medicines within and between countries [21]. While
this study was not designed using the WHO/HAI Medi-
cine Prices protocol, in as much as possible the study
adapted methodologies recommended in the protocol.
The cross-sectional, multi-country nature of the study and
prices obtained from retail outlets prevented the same
comparisons.
Global indicators used to facilitate comparisons
WHO/HAI suggests comparing "the cost of therapy with
the daily wage of the lowest paid government worker
[21]." The current study did not utilise wage information
since it was not readily available; instead, household final
consumption expenditures were used as a proxy for
annual income.
Toothpaste (annual dosage) at lowest price as a proportion of annual household expenditures per capita Figure 1
Toothpaste (annual dosage) at lowest price as a proportion of annual household expenditures per capita. Cost 
of one annual dosage of toothpaste at the lowest price as a proportion of annual household expenditures per capita by popula-
tion group for selected countries.
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The authors of this study recognise that all indicators,
whether household data, income distribution or total
health expenditure, possess limitations which make cross-
country comparisons difficult. Therefore, future assess-
ments of fluoride toothpaste affordability may benefit
from the application of 'research triangulation'[23] as well
as the use of multiple indices to further investigate this
issue.
Ratios were calculated for the poorest 30%, 50% and 70%
of the population and the total population. The ratios for
the poorest 30% and the total population are reported to
provide a sense of the difference in impact on the total
population, compared to the strata of the poorest sector of
the population with the greatest health needs and least
access to services, including health and dental services.
Access to a preventive measure like fluoride toothpaste
has a potentially huge positive impact on these popula-
tions.
Discussion
Inequities in global affordability of fluoride toothpaste
The results of this study clearly demonstrate significant
inequities in the affordability of fluoride toothpaste.
There is a general trend where the poorer the country, the
larger the proportion of the household expenditure that is
needed to pay for one annual dosage of toothpaste for one
person. In the 13 high-income nations the cost of tooth-
paste represents less than one percent of per capita house-
hold consumption expenditures, ranging from 0.004% to
0.041%. Toothpaste products surveyed in the middle- and
low-income countries showed the proportion of house-
hold expenditure required to acquire one annual thera-
peutic dose of toothpaste is considerably larger and
variable.
Two publications connected to the WHO-HAI studies
state that a treatment regimen costing one or five days is
considered expensive, and that these numbers are debata-
ble [24]. While fluoride toothpaste is considered essential
for the prevention of dental decay and its use should be
part of daily hygiene, it should be more accessible and
Days of household expenditures to pay for toothpaste (one person, one year) at the lowest price Figure 2
Days of household expenditures to pay for toothpaste (one person, one year) at the lowest price. Number of 
days of household expenditures required to pay for one annual dosage of toothpaste at the lowest price by country and popu-
lation group. This figure includes countries for which the proportion was greater than 10% of a day of household expenditures.
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cheaper than life-saving medicines. On the basis of the
survey results we suggest that a different metric is needed
to establish a threshold for affordability, wherein the abil-
ity to pay of the poorest income groups, as well as a viable
sales price are taken into account.
Measures to reduce the costs of fluoride toothpaste
Equity Pricing
Equity pricing is based on the principle that the poor
should pay less for, and have better access to an effective
preventive product. The price of fluoride toothpaste
should be fair, equitable and affordable, even for poor
communities. The same brand of toothpaste should be
available at different prices in different countries in
accordance with the peoples' purchasing power.
Removal of taxation and tariffs
Taxes and tariffs on fluoride toothpaste sometimes signif-
icantly contribute to higher prices, lower demand and
inequity since they target the poor. Toothpastes are usu-
ally classified as a cosmetic product and as such often
highly taxed by governments. For example, various taxes
such as excise tax, VAT, local taxes as well as taxation on
the ingredients and packaging contribute to 25% of the
retail cost of toothpaste in Nepal and India, and 50% of
the retail price in Burkina Faso. In many developing coun-
tries essential preventive products, such as insecticide-
treated mosquito nets, vaccines, contraceptives and oral
rehydration salts, are exempt from import taxes or benefit
from partial tax relief [25]. Olcay and Laing [24] found
that pharmaceutical tariffs could be eliminated without
adversely impacting on government revenue or industrial
policy. There is also a significant negative relationship
between the levels of tariffs and access to essential medi-
cines. Analysis suggests that a 1% reduction in taxation
will increase access to essential medicines by approxi-
mately 1% [26]. These findings may also be valid for flu-
oride toothpastes; hence, WHO continues to recommend
the removal taxes and tariffs on fluoride toothpastes
[5,27]. Any lost revenue can be restored by higher taxes on
sugar and high sugar containing foods [28], which are
common risk factors for dental caries, coronary heart dis-
ease, diabetes and obesity [29]. Along with tax relief on
quality fluoride toothpaste, taxation of non-fluoride
toothpaste, which has little preventive properties [30,31]
would encourage consumers to make 'healthy choices the
easy choices'. Any savings from tax relief on fluoride
toothpastes must however be passed on to the customer.
Generic competition
Generic competition has been a powerful strategy for
reducing drug prices and may have the same potential for
increasing the availability and affordability of tooth-
pastes. During the first half of the 1980s, world market
prices for drugs on the WHO Model List fell by 40%
through increased demand and competition [32]; while
in Brazil the price of AIDS drugs fell by 82% over 5 years
as a result of generic competition. In Myanmar, generic
fluoride toothpaste is manufactured and distributed by
the government – it is 3.5 times less expensive than the
most expensive imported brand [33]. Social marketing
has been successful in the prevention of HIV/AIDS and
malaria [34,35] and has been proposed for increasing the
availability and affordability of fluoride toothpaste [36].
Encouraging local production
The production of toothpaste within a country has the
potential to make fluoride toothpaste more affordable
than imported products. In Nepal, fluoride toothpaste
was limited to expensive imported products. However,
due to successful advocacy for locally manufactured fluo-
ride toothpaste, the least expensive locally manufactured
fluoride toothpaste is now 170 times less costly than the
most expensive import [37]. In the Philippines, local
manufacturers are able to satisfy consumer preferences
and compete against multinationals by discounting the
price of toothpaste by as much as 55% against global
brands; and typically receive a 40% profit margin com-
pared to 70% for multinational producers [38].
Inexpensive ingredients and packaging
Approximately 40% of the cost of production of tooth-
paste is related to the packaging, another 40% to the
ingredients and 20% to labour [38]. High quality low cost
fluoride toothpaste can be produced using (cheaper) pre-
cipitated calcium carbonate without interfering with the
in vitro anti-caries efficacy [39]. Many countries use sachet
packaging (10 ml) which make fluoride toothpaste more
affordable to the poor who cannot afford a one-time
expenditure for a larger quantity.
In order to achieve these measures, advocacy by interna-
tional health organisations such as the WHO and the FDI
World Dental Federation, as well as national advocacy by
oral health stakeholders, is required in order to:
￿ Transform government policies and regional trade poli-
cies to eliminate taxation of quality fluoride toothpaste;
￿ Encourage generic and local production of affordable
fluoride toothpaste.
￿ Encourage multinational toothpaste manufacturers to
implement differential pricing for poorer countries and
reduce the cost of toothpaste through inexpensive packag-
ing and cheaper ingredients;
Conclusion
World experts at a conference on "Oral Health through
Fluoride for China and Southeast Asia" on September 18–Globalization and Health 2008, 4:7 http://www.globalizationandhealth.com/content/4/1/7
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19, 2007, in Beijing, China, have confirmed that: "fluo-
ride toothpaste remains the most widespread and signifi-
cant form of prevention of and protection against tooth
decay used worldwide. It is also the most rigorously eval-
uated vehicle for fluoride use" [40]. In view of the current
extremely inequitable use of fluoride throughout coun-
tries and regions, all efforts to make fluoride and fluoride
toothpaste affordable and accessible must be intensified.
As a first step to addressing the issue of affordability of flu-
oride toothpaste in the poorer countries in-depth country
studies should be undertaken to analyze the price of
toothpaste in the context of the country economies.
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